---
schema_version: "secwatch.filing_event.v1"
accession: "0001570562-24-000049"
form_type: "8-K"
ticker: "EOLS"
cik: "0001570562"
company_name: "Evolus, Inc."
filed_at: "2024-03-13T23:59:59+00:00"
generated_at: "2026-06-04T22:15:08.433305+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Evolus prices public offering of 3.55M shares at $14.07/share; net proceeds ~$46.9M

## Summary
- Underwriters Leerink and Stifel purchase 3,554,000 shares at $13.2258/share; option for 533,100 more.
- Estimated net proceeds of $46.9M (up to $54.1M if option exercised) to fund Jeuveau growth, Evolysse launch.
- Lock-up agreements restrict insider sales for 60 days from March 11, 2024.
- Offering closed on March 13, 2024; proceeds also for potential business development.

## SEC filing metadata
- accession: 0001570562-24-000049
- form_type: 8-K
- ticker: EOLS
- cik: 0001570562
- company_name: Evolus, Inc.
- filed_at: 2024-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1570562/000157056224000049/0001570562-24-000049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1570562/000157056224000049/eols-20240311.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001570562-24-000049
- JSON: https://secwatch.observer/filing/0001570562-24-000049.json
- Plain text: https://secwatch.observer/filing/0001570562-24-000049.txt

## Key facts
- Material Agreements
  Evolus, Inc. entered into Underwriting Agreement with Leerink Partners, LLC and Stifel, Nicolaus & Company, Incorporated as representatives of the underwriters named in Schedule A valued at approximately $46.9 million (effective 2024-03-11).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Leerink Partners, LLC and Stifel, Nicolaus & Company, Incorporated as representatives of the underwriters named in Schedule A
  - Value: approximately $46.9 million
  - Effective: 2024-03-11
  source text: On March 11, 2024, Evolus, Inc., a Delaware corporation (the “Company”), entered into an underwriting agreement (the “Underwriting Agreement”) with Leerink Partners, LLC and Stifel, Nicolaus & Company, Incorporated as representatives of the underwriters named in Schedule A thereto (together, the “Underwriters”), in connection with the underwritten public offering, issuance and sale by the Company (the “Offering”) of 3,554,000 shares (the “Firm Shares”) of the Company’s common stock, par value $0.00001 per share (the “Common Stock”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1570562/000157056224000049/0001570562-24-000049-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.